CULLINAN ASSOCIATES INC – Vertex Pharmaceuticals Incorporated Transaction History
CULLINAN ASSOCIATES INC portfolio value:
$24.40M
portfolio value
CULLINAN ASSOCIATES INC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -5.23% | -4.65K shares | -657K | $289.54 | 84.28K |
Q2 2022 | share | Decrease | -9.55% | -9.38K shares | -598K | $281.79 | 88.93K |
Q1 2022 | share | Decrease | -0.60% | -594 shares | 3.93M | $260.97 | 98.31K |
Q4 2021 | share | Decrease | -0.22% | -215 shares | 3.74M | $222.45 | 98.91K |
Q3 2021 | share | Decrease | -2.57% | -2.61K shares | -2.53M | $181.39 | 99.12K |
Q2 2021 | share | Decrease | -2.59% | -2.7K shares | -1.92M | $201.63 | 101.73K |
Q1 2021 | share | Increase | +11.53% | 10.8K shares | 312K | $214.89 | 104.43K |
Q4 2020 | share | Increase | +5.55% | 4.92K shares | -2.01M | $236.34 | 93.63K |
Q3 2020 | share | Decrease | -6.02% | -5.67K shares | -3.26M | $272.12 | 88.71K |
Q2 2020 | share | Increase | +1.59% | 1.47K shares | 5.29M | $290.31 | 94.38K |
Q1 2020 | share | Increase | +1.80% | 1.64K shares | 2.12M | $237.95 | 92.91K |
Q4 2019 | share | Decrease | -10.60% | -10.82K shares | 2.68M | $218.95 | 91.27K |
Q3 2019 | share | 0.00% | 0 shares | -1.42M | $169.42 | 102.09K | |
Q2 2019 | share | Decrease | -7.58% | -8.37K shares | -1.6M | $183.38 | 102.09K |
Q1 2019 | share | Decrease | -5.80% | -6.8K shares | 889K | $183.95 | 110.47K |
Q4 2018 | share | Increase | +4.89% | 5.47K shares | -2.11M | $165.71 | 117.27K |
Q3 2018 | share | Decrease | -7.10% | -8.54K shares | 1.09M | $192.74 | 111.80K |
Q2 2018 | share | Increase | +22.12% | 21.79K shares | 4.39M | $169.96 | 120.34K |
Q1 2018 | share | Increase | +0.61% | 600 shares | 1.38M | $162.98 | 98.54K |
Q4 2017 | share | Increase | +1.13% | 1.09K shares | -48K | $149.86 | 97.94K |
Q3 2017 | share | Decrease | -11.04% | -12.01K shares | 696K | $152.04 | 96.85K |
Q2 2017 | share | Increase | +24.96% | 21.74K shares | 4.50M | $128.87 | 108.86K |
Q1 2017 | share | Decrease | -30.42% | -38.08K shares | 303K | $109.35 | 87.12K |
Q4 2016 | share | Decrease | -2.19% | -2.8K shares | -1.94M | $73.67 | 125.21K |
Q3 2016 | share | 0.00% | 0 shares | 153K | $87.21 | 128.01K | |
Q2 2016 | share | Increase | +27.14% | 27.32K shares | 3.00M | $86.02 | 128.01K |
Q1 2016 | share | 0.00% | 0 shares | -4.66M | $79.49 | 100.68K |